Yamin Khan
Fortuna: 828 789 $ al 31/07/2026
Fortuna: 828 789 $ al 31/07/2026
Yamin Mohammed Khan is currently Chief Executive Officer & Director at hVIVO PLC since 2022 and EVP-Global Clinical Development at Pharm-Olam International Ltd. since 2009.
Formerly, Mr. Khan was Chief Revenue Officer at Allucent (UK) Ltd. from 2000 to 2019.
Education includes an undergraduate degree from The University of Liverpool and a doctorate from The University of Southampton.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HVIVO PLC 1,21 % | 15/12/2025 | 8.322.008 ( 1,21 % ) | 828 789 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HVIVO PLC | Director Ejecutivo | 24/02/2022 |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotechnology, government and public health organizations | Corporate Officer/Principal | 11/11/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
Pharm-Olam International (UK) Ltd.
Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Engages in management and consulting of clinical research trials | Corporate Officer/Principal | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotechnology, government and public health organizations | Commercial Services |
Pharm-Olam International (UK) Ltd.
Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Engages in management and consulting of clinical research trials | Health Technology |
hVIVO PLC
hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.